Objective Intrahepatic cholestasis of pregnancy (ICP) is the most frequently encountered pregnancy-specific hepatic disease that may cause obstetric complications such as spontaneous preterm birth, fetal distress, meconium-stained amnion fluid and stillbirth. This study aimed to retrospectively analyze the pregnancy-related and fetal outcomes of patients who were diagnosed with ICP. Materials and Methods This is a retrospective and descriptive study, where patients who were diagnosed with ICP between November 2017 and September 2019 were included. Pregnant women who visited with the complaint of itching, had constant itching and increased bile acids in the maternal blood (≥10 μmol/L) without any liver or skin pathology were accepted as ICP. For the cases(n=44) that were included in the study, data on demographic characteristics, liver enzymes, week of pregnancy at diagnosis, duration of exposure to the disease, type of delivery, time of delivery, APGAR scores and the weight of the newborn were collected by reviewing the hospital records. Results The mean age of the participants was 26,77±6,23, while 61,40% were nulliparous. The mean time of diagnosis was 35,52±1,72 weeks, while the mean week of pregnancy was 36,64±1,78. The mean duration of exposure to the disease was calculated as 7,54±8,14 days. 17 of the pregnant women (38,60%) gave birth via normal vaginal delivery, while 27 (61,40%) gave birth by Cesarean section delivery. The pregnancy complications were found as preterm birth (n=16), gestational diabetes (n=1) and preeclampsia (n=1). There was no in utero fetal death. Conclusion Intrahepatic cholestasis of pregnancy causes significant maternal and fetal complications. Close monitoring and active management are required in prevention of these complications.